In this section, we utilised an animal model that is more analogous to human bladder cancer to ultimately substantiate the role of NAT10 in regulating the expression of targets such as BCL9L, SOX4 and AKT1 through ac4C modification, therefore, promoting BLCA progression. Here, BCL9L is linked to urinary bladder cancer.